TIOTROPIUM GH (Lupin Australia Pty Limited)
Product name
TIOTROPIUM GH
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
103 (255 working days)
Active ingredients
Tiotropium bromide monohydrate
Registration type
New generic medicine
Indication
TIOTROPIUM LUPIN, TIOTROPIUM GH is indicated for long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (COPD). TIOTROPIUM LUPIN, TIOTROPIUM GH is indicated for the prevention of COPD exacerbations.